Entity Common Stock, Shares Outstanding of Neuphoria Therapeutics Inc. from Q2 2022 to Q3 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Neuphoria Therapeutics Inc. quarterly Entity Common Stock, Shares Outstanding history and change rate from Q2 2022 to Q3 2025.
  • Neuphoria Therapeutics Inc. Entity Common Stock, Shares Outstanding for the quarter ending 29 Sep 2025 was 2,357,613, a 100% decline year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Neuphoria Therapeutics Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 2,357,613 -3,115,305,251 -100% 29 Sep 2025 10-K 29 Sep 2025 2025 FY
Q2 2025 1,879,962 16 May 2025 10-Q 20 May 2025 2025 Q3
Q4 2024 1,757,027 12 Feb 2025 10-Q 14 Feb 2025 2025 Q2
Q3 2024 3,117,662,864 17 Sep 2024 10-K 30 Sep 2024 2024 FY
Q2 2023 1,486,735,424 +133,384,680 +9.9% 30 Jun 2023 20-F/A 17 Jan 2024 2023 FY
Q2 2022 1,353,350,744 30 Jun 2022 20-F 14 Oct 2022 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.